Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation

Attention to issues of quality assurance from the early stages of development of experimental cell therapies provides a margin of safety for recipients. Adherence to minimum standards of practice at acquisition, processing, storage, and implantation ensures not only this baseline safety factor for p...

Full description

Bibliographic Details
Main Author: Helen Newman-Gage
Format: Article
Language:English
Published: SAGE Publishing 1995-09-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/096368979500400506
id doaj-4c5404e0c09246dbb3d5ea05e0dc5111
record_format Article
spelling doaj-4c5404e0c09246dbb3d5ea05e0dc51112020-11-25T03:33:14ZengSAGE PublishingCell Transplantation0963-68971555-38921995-09-01410.1177/096368979500400506Application of Quality Assurance Practices in Processing Cells and Tissues for TransplantationHelen Newman-Gage0Northwest Tissue Center, A Department of the Puget Sound Blood Center, 921 Terry Avenue, Seattle, WA 98104; and Department of Orthopaedics, University of Washington, Seattle, WA 98195Attention to issues of quality assurance from the early stages of development of experimental cell therapies provides a margin of safety for recipients. Adherence to minimum standards of practice at acquisition, processing, storage, and implantation ensures not only this baseline safety factor for patients, but also provides a baseline for comparative evaluations between different studies or different banks. This paper describes the basic components of a quality assurance program tailored to laboratories and facilities that collect, process, or distribute human cells and tissues for transplantation. These components include policy and procedure manuals, donor screening practices, processing procedures evaluation and control, training and education programs, auditing and investigation roles, responsibility for release of grafts, and recordkeeping and traceability requirements. References and resources for detailed information related to good manufacturing practices and good clinical and laboratory practices are provided. Standards, regulations, and current legislation specifically related to human cells and tissues intended for transplantation are also discussed.https://doi.org/10.1177/096368979500400506
collection DOAJ
language English
format Article
sources DOAJ
author Helen Newman-Gage
spellingShingle Helen Newman-Gage
Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation
Cell Transplantation
author_facet Helen Newman-Gage
author_sort Helen Newman-Gage
title Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation
title_short Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation
title_full Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation
title_fullStr Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation
title_full_unstemmed Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation
title_sort application of quality assurance practices in processing cells and tissues for transplantation
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 1995-09-01
description Attention to issues of quality assurance from the early stages of development of experimental cell therapies provides a margin of safety for recipients. Adherence to minimum standards of practice at acquisition, processing, storage, and implantation ensures not only this baseline safety factor for patients, but also provides a baseline for comparative evaluations between different studies or different banks. This paper describes the basic components of a quality assurance program tailored to laboratories and facilities that collect, process, or distribute human cells and tissues for transplantation. These components include policy and procedure manuals, donor screening practices, processing procedures evaluation and control, training and education programs, auditing and investigation roles, responsibility for release of grafts, and recordkeeping and traceability requirements. References and resources for detailed information related to good manufacturing practices and good clinical and laboratory practices are provided. Standards, regulations, and current legislation specifically related to human cells and tissues intended for transplantation are also discussed.
url https://doi.org/10.1177/096368979500400506
work_keys_str_mv AT helennewmangage applicationofqualityassurancepracticesinprocessingcellsandtissuesfortransplantation
_version_ 1724563871063080960